Suppr超能文献

Th1 和 Th2 相关趋化因子受体在复发性流产妇女中的表达:淋巴细胞免疫治疗的影响。

The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy.

机构信息

Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Am J Reprod Immunol. 2010 Aug 1;64(2):104-12. doi: 10.1111/j.1600-0897.2010.00829.x. Epub 2010 Mar 22.

Abstract

PROBLEM

Recurrent miscarriage (RM) is defined as three or more consecutive pregnancy losses prior to the 20th week of gestation. The aim of this study was to investigate the expression of T helper (Th)1- and Th2-related chemokine receptors on CD4(+) T helper and CD8(+) T cytotoxic (Tc) cells in RM and control subjects. The effects of lymphocyte immunotherapy on the balance of Th1/Th2 and Tc1/Tc2 chemokine receptors were further evaluated in RM women.

METHOD OF STUDY

The expression of Th1-related (CCR5 and CXCR3) and Th2-related (CCR3 and CCR4) chemokine receptors on CD4(+) or CD8(+) T cells from RM women were analyzed and compared with controls using flow cytometry. The expression of chemokine receptors in RM women was also compared before and after lymphocyte immunotherapy.

RESULTS

The ratios of Th1/Th2 and Tc1/Tc2 chemokine receptors were higher in RM women compared to controls. The ratio of Th1/Th2 chemokine receptors was decreased in RM women after immunotherapy, while no significant change was identified in the Tc1/Tc2 after immunotherapy.

CONCLUSION

This study indicates the Th1 dominant immune responses in circulation of RM women compared to controls. Moreover, lymphocyte immunotherapy might influence pregnancy outcome via a shift in the balance of the Th1/Th2 chemokine receptors.

摘要

问题

复发性流产(RM)定义为妊娠 20 周前连续发生三次或更多次妊娠丢失。本研究旨在研究 CD4+T 辅助和 CD8+T 细胞毒性(Tc)细胞中 Th1 和 Th2 相关趋化因子受体在 RM 和对照组中的表达。进一步评估淋巴细胞免疫疗法对 RM 女性 Th1/Th2 和 Tc1/Tc2 趋化因子受体平衡的影响。

研究方法

采用流式细胞术分析和比较 RM 女性和对照组 CD4+或 CD8+T 细胞中 Th1 相关(CCR5 和 CXCR3)和 Th2 相关(CCR3 和 CCR4)趋化因子受体的表达。比较 RM 女性淋巴细胞免疫治疗前后趋化因子受体的表达。

结果

RM 女性 Th1/Th2 和 Tc1/Tc2 趋化因子受体的比值高于对照组。免疫治疗后 RM 女性 Th1/Th2 趋化因子受体的比值降低,而免疫治疗后 Tc1/Tc2 无明显变化。

结论

本研究表明 RM 女性循环中 Th1 优势免疫反应与对照组相比。此外,淋巴细胞免疫疗法可能通过改变 Th1/Th2 趋化因子受体的平衡影响妊娠结局。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验